Business · 15/08/1994Updated: 10/16/2026 · 1 min read
Clinical Studies of Safety and Effectiveness of Orphan Products; Availability of Grants; Request for Applications
Summary
The Food and Drug Administration (FDA) is combining two separate requests for applications into one notice with two receipt dates each year for its Orphan Products Development grant program.
Original source language: Federal Register — Health and Human ServicesOpen original release →